Katherine Tallman Landschulz

Title: Katherine Tallman Landschulz: Innovator in Lipid Uptake Regulation

Introduction

Katherine Tallman Landschulz is a notable inventor based in Dallas, TX (US). She has made significant contributions to the field of lipid metabolism through her innovative research and patent work. Her expertise lies in the modulation of lipid and cholesterol uptake, which has important implications for health and disease management.

Latest Patents

Katherine holds a patent titled "Methods for modulation of lipid uptake." This patent describes methods for regulating lipid and cholesterol uptake based on the expression or function of the SR-BI HDL receptor. The research highlights how estrogen dramatically downregulates SR-BI under conditions of significant upregulation of the LDL-receptor. Additionally, it demonstrates the upregulation of SR-BI in rat adrenal membranes and other non-placental steroidogenic tissues treated with estrogen, while showing no effect in non-steroidogenic tissues such as the lung, liver, and skin. The patent also illustrates the uptake of fluorescently labeled HDL into liver cells, which is inhibited when animals are treated with estrogen.

Career Highlights

Katherine is affiliated with the University of Texas System, where she continues her research and development in lipid metabolism. Her work has garnered attention for its potential applications in understanding and treating metabolic disorders.

Collaborations

Katherine has collaborated with esteemed colleagues, including Monty Krieger and Susan Laurene Acton, to advance her research in lipid uptake and regulation.

Conclusion

Katherine Tallman Landschulz is a pioneering inventor whose work in lipid uptake regulation is paving the way for future advancements in metabolic health. Her contributions are vital to the ongoing research in this important field.